What is the total daily morphine‑milligram equivalent (MME) for a patient taking Norco (hydrocodone 10 mg/acetaminophen 325 mg) every 6 hours and methadone 20 mg three times daily?

Total Daily MME Calculation

The total daily MME for this patient is 320.5 MME/day, placing them in the high-dose category (≥90 MME/day) with significantly elevated overdose risk. 1

Calculation Breakdown

Norco (Hydrocodone/Acetaminophen 10/325 mg every 6 hours)

• Daily hydrocodone dose: 10 mg × 4 doses = 40 mg/day 1
• Conversion factor for hydrocodone: 1.0 1, 2
• Hydrocodone MME contribution: 40 mg × 1.0 = 40 MME/day 1

Methadone 20 mg three times daily

• Daily methadone dose: 20 mg × 3 doses = 60 mg/day 1
• Conversion factor for methadone: 4.7 1, 2
• Methadone MME contribution: 60 mg × 4.7 = 282 MME/day 1

Combined Total

• Total daily MME: 40 + 282 = 320.5 MME/day 1

Critical Safety Considerations

High-Dose Threshold Exceeded

• This patient's total MME of 320.5 mg/day is more than 3.5 times the 90 MME/day threshold at which the CDC recommends avoiding dose escalation or carefully justifying continuation based on documented incremental benefits in pain and function 1
• At ≥90 MME/day, overdose risk increases substantially, and clinicians must implement enhanced monitoring protocols including more frequent follow-up visits and offering naloxone 1

Methadone-Specific Warnings

• Methadone carries unique risks due to its long and variable half-life, with peak respiratory depression occurring later and persisting longer than its analgesic peak 1, 3
• The methadone conversion factor of 4.7 is a risk-assessment estimate only and does not account for individual pharmacokinetic variability 1
• Deaths have been reported during methadone dose titration and conversion, even in opioid-tolerant patients 3

Acetaminophen Monitoring

• Although the 325 mg acetaminophen component does not contribute to MME, the patient receives 1,300 mg acetaminophen daily (325 mg × 4 doses), which is well below the 4,000 mg/day maximum but must be tracked if the patient takes any other acetaminophen-containing products 1

Clinical Action Required

• Immediate reassessment of whether this high-dose regimen provides measurable benefits in pain control and functional improvement that justify the elevated overdose risk 1
• If pain and function are not improving at this dose level, discuss alternative pain management approaches and consider tapering 1
• Ensure naloxone is prescribed and the patient/caregivers are trained in its use 1
• Screen for concurrent benzodiazepine use, which significantly amplifies overdose risk at any opioid dose 1